Innovations and Emerging Technologies in the Regulated Environment of Pharma Effective training programs are essential for maintaining compliance, improving operational efficiency, and ensuring data ...
See how Compliance Group helps life sciences organizations adopt and validate AI with confidence through CLAiRE AI Agents and the iQuality Platform. Each slot accommodates up to 4 attendees.
The FDA’s CSA guidance is final. Every validation project executed the old way is time and money you won’t get back—and audit exposure you can’t afford. Here is an uncomfortable truth for quality ...
These case studies highlight how Compliance Group has successfully implemented AI-driven solutions across diverse business environments. Each case study demonstrates the practical application of ...
On April 2, 2026, the FDA issued a warning letter that should be on the desk of every Quality leader in life sciences. It cites several familiar deviations — but embedded in the findings is something ...
We’re excited to announce that Compliance Group will be attending the Realize LIVE Americas 2026 conference, happening in Detroit, Michigan from June 1–4, 2026. This premier industry event, hosted by ...
The shift from QSR to QMSR is now in full effect. The FDA has aligned 21 CFR Part 820 with ISO 13485:2016, effective Feb 2026. While this alignment eases global compliance, many MedTech companies ...
As the pace of digital transformation and automation accelerates, the need for a robust and lean risk assessment methodology for software is becoming more and more critical in the life sciences ...
The development of new medical devices or any new project brings a new set of risks. A Risk Management Plan (RMP) must be developed at the start of the Risk Management Process for a new project or ...
In the life sciences industries, documentation plays a crucial role in proving the product's effectiveness and safety. Furthermore, it discusses the processes and practice's dependability, ...
Computer Software Assurance (CSA) is a new methodology that takes a risk-based approach to validation activities. It was driven by the FDA and life sciences industry to streamline verification and ...
The US Food and Drug Administration (FDA) is responsible for protecting public health by ensuring medical devices' safety, efficacy, and quality. The agency has developed a rigorous medical device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results